Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
Heart drug aficamten under Long-Term safety watch in 900 patients
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called aficamten for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. About 900 adults who have already taken aficamten in earlier studies will continue taking it and be monitored for si…
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New heart drug aficamten aims to boost exercise and quality of life in major trial
Symptom relief OngoingThis study tests whether a drug called aficamten can improve quality of life and exercise ability in adults with a specific type of heart muscle disease (non-obstructive hypertrophic cardiomyopathy). About 500 participants will receive either aficamten or a placebo. The goal is t…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Symptom relief
Last updated May 26, 2026 09:02 UTC